Table 3 Comparison of SV VD of CAS group A versus CAS group B patients. Patients with CAS 0–2 were categorized as group A and scored three or more as group B. (SV: small vessels; VD: vessel density; SD: Standard Deviation; TED: thyroid eye disease; CAS: Clinical Activity Score)
CAS group A (n:18) Mean ± SD (Range) | CAS group B (n:11) Mean ± SD (Range) | P-value | |
|---|---|---|---|
Whole image SV VD | 50.95 ± 1.37 (48.40–53.50) | 48.60 ± 3.18 (40.20–52.80) | 0.013 |
Inside disc SV VD | 49.83 ± 3.88 (43.80–55.80) | 46.59 ± 6.24 (37.50–60) | 0.103 |
Whole peripapillary SV VD | 53.88 ± 1.38 (51.40–55.90) | 51.35 ± 4.63 (38.20–55) | 0.092 |
Peripapillary superior hemifield SV VD | 54.12 ± 1.61 (51.40–56.50) | 51.80 ± 4.59 (38.60–55.70) | 0.072 |
Peripapillary inferior hemifield SV VD | 53.58 ± 2.04 (49.60–56.20) | 50.87 ± 4.84 (37.70–55) | 0.045 |
Peripapillary nasal superior SV VD | 50.55 ± 3.26 (41.20–54.20) | 49.81 ± 6.31 (38.30–60) | 0.682 |
Peripapillary nasal inferior SV VD | 49.15 ± 3.12 (43.50–54.40) | 46.74 ± 5.71 (35.90–58.00) | 0.155 |
Peripapillary inferior nasal SV VD | 52.05 ± 3.73 (46.50–58.30) | 50.51 ± 6.71 (35.90–59.90) | 0.437 |
Peripapillary inferior temporal SV VD | 58.97 ± 3.65 (49.80–62.30) | 57.67 ± 4.53 (51.70–64.80) | 0.647 |
Peripapillary temporal inferior SV VD | 54.88 ± 3.80 (48.70–61.10) | 51.30 ± 6.48 (40.60–62.00) | 0.073 |
Peripapillary temporal superior SV VD | 56.29 ± 3.14 (49.10–60.50) | 54.85 ± 5.38 (46.80–63.40) | 0.373 |
Peripapillary superior temporal SV VD | 57.17 ± 2.94 (51.30–62.60) | 54.20 ± 6.30 (43.00–61.50) | 0.152 |
Peripapillary superior nasal SV VD | 51.28 ± 3.33 (42.10–56.20) | 49.53 ± 6.89 (34.90–61.50) | 0.371 |